Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Adrenaline vs Adenosine for No-Reflow in ACS
NCT04699110Phase 4Completed
- Sponsor
- National Institute of Cardiovascular Diseases
- Start
- Jan 2021
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epinephrine in no-reflow phenomenon, sponsored by National Institute of Cardiovascular Diseases. Started Jan 2021; status: completed.
02
Drugs
epinephrine
03
Conditions
no-reflow phenomenon
Beyond the preview
Go deeper on NCT04699110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04699110.